ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2015

MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer.

Hao Fu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.